beclomethasone dipropionate · Teva Branded Pharm · NDA 202813
Qnasl
Earliest generic entry, as listed · earliest of 2 marketed strengths
21 Oct 2031
Blocked by patent: US 10188811.
Listed patents · 1 unexpired
| Patent | Claims | Expires |
|---|---|---|
| US 10188811 | product | 21 Oct 2031 |
Exclusivities · 0 unexpired
No unexpired exclusivities listed.
Paragraph IV certifications · 0
No Paragraph IV certification listed by FDA for this drug.
The list shows that a generic applicant certified to FDA that a listed patent is invalid or not infringed. It does not show litigation, settlements or launch timing.
Event history
No events yet. The first ingestion only records products entering their 12-month window; changes appear from the next Orange Book update.
Products covered · 2
| NDA · product | Form | Strength | Listed expiry |
|---|---|---|---|
| 202813 · 001 · RLD | aerosol, metered, nasal | 0.08MG/ACTUATION | 21 Oct 2031 |
| 202813 · 002 · RLD | aerosol, metered, nasal | 0.04MG/ACTUATION | 21 Oct 2031 |